The relationship between neopterin and hepatitis B surface antigen positivity
dc.authorid | KARAKUŞ, Fuat/0000-0002-5260-3650 | |
dc.authorid | Ünüvar, Songül/0000-0001-8454-490X | |
dc.authorwosid | KARAKUŞ, Fuat/O-2627-2019 | |
dc.authorwosid | Ünüvar, Songül/ABH-5516-2020 | |
dc.contributor.author | Unuvar, Songul | |
dc.contributor.author | Aslanhan, Hamza | |
dc.contributor.author | Tanriverdi, Zubeyde | |
dc.contributor.author | Karakus, Fuat | |
dc.date.accessioned | 2024-08-04T20:44:24Z | |
dc.date.available | 2024-08-04T20:44:24Z | |
dc.date.issued | 2018 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Hepatitis B is a life-threatening viral liver infection caused by the hepatitis B virus. Neopterin is regarded as an immunologic biomarker of several diseases related to activation of the cellular immune system. Hepatitis B infection is associated with increased production of cellular immune system markers. We aimed to investigate whether there is a relationship between hepatitis B surface antigen-positivity (HBsAg +) and neopterin to determine the role of neopterin in the early diagnosis of hepatitis B infections. Seventy-two HBsAg (+) patients with normal liver function tests and forty-three controls were included in the study. Neopterin levels were 17.6 +/- 0.13 nmol/L in HBsAg (+) patients; and 9.12 +/- 0.09 nmol/L in infection-free controls, respectively. Compared to the control group, a statistically significant increase (p < 0.001) in the serum neopterin levels of the patients was observed. No significant relationship was determined between neopterin levels and age/sex (both, p > 0.05). With overstimulation of interferon-gamma, the production of neopterin increases by monocytes/macrophages. Likewise with other diseases associated with an activated cellular immune system, this study shows that neopterin can be a predictive biomarker for persistent carriers of hepatitis B infection. | en_US |
dc.identifier.doi | 10.1515/pteridines-2018-0001 | |
dc.identifier.endpage | 5 | en_US |
dc.identifier.issn | 0933-4807 | |
dc.identifier.issn | 2195-4720 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85043775599 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | https://doi.org/10.1515/pteridines-2018-0001 | |
dc.identifier.uri | https://hdl.handle.net/11616/98197 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:000428142600001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | De Gruyter Poland Sp Z O O | en_US |
dc.relation.ispartof | Pteridines | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | hepatitis B surface antigens | en_US |
dc.subject | immune system | en_US |
dc.subject | interferon-gamma | en_US |
dc.subject | liver diseases | en_US |
dc.subject | neopterin | en_US |
dc.title | The relationship between neopterin and hepatitis B surface antigen positivity | en_US |
dc.type | Article | en_US |